Clinical characteristics, sight of PSMA uptake and subsequent workup, treatment and follow‐up of 8 patients with PET PSMA initially suspicious of metastatic disease ultimately treated with definitive local therapy. This evidence concerns the gene FOLH1 and metastatic neoplasm.